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ABSTRACT: Transfusion, just as any other medical intervention has both benefits and 
risks, which should be balanced for each patient so that the benefits outweigh the risks. 
Blood and its products are considered drugs and hence careful consideration of therapy is 
essential  to  minimize  the  potential  adverse  reactions.  Moreover,  alternative  modes  of 
treatment  should  be  considered  and  final  decision  to  transfuse  should  be  based  on 
individual patient evaluation. Reviews of blood transfusion practices have found that most 
surgical  procedures  do  not  require  blood  transfusion.  This  review  is  focused  on  the 
transfusion needs of the surgical patients. 
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INTRODUCTION
ᴪ 
 
Blood transfusion services play a pivotal role in the 
field of medical science. The availability of blood 
led  to  the  development  of  transfusion  based 
surgical technologies and operations, which include 
cardiac, vascular, oncologic and joint replacement 
surgeries.  The  key  objective  of  any  surgical  or 
anesthetic practice is reduction of patient morbidity 
and mortality. In addition, the decision to transfuse 
a  surgical  patient  can  often  be  difficult.  In  some 
surgical procedures, significant blood loss can be 
anticipated  though  there  is  a  potential  for 
unexpected blood loss to occur during any type of 
surgery.  However,  most  effective  and  planned 
surgeries may not result in sufficient blood loss to 
require a blood transfusion. 
Over the years, the trigger for blood transfusion has 
shifted  from  an  optimal  hemoglobin  level  to  one 
that is required to meet the oxygen demands of the 
tissues. A number of autologous blood options are 
available  that  can  decrease  the  demand  for 
allogeneic blood transfusion. Besides, alternatives 
such as erythropoietin and blood substitutes have 
revolutionized the management of surgical patients. 
Reduction of intraoperative blood loss by the use of 
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pharmacologic  agents  further  contributes  to 
decrease in exposure to allogeneic blood.   
 
ANEMIA & SURGERY 
 
Although allogeneic blood transfusion has become 
increasingly safe, the risk of transmissible diseases 
and  transfusion  reactions  has  not  been  entirely 
eliminated.  Alternatives  to  allogeneic  transfusion 
include  preoperative  autologous  blood  donation 
and  priming  with  erythropoietin.  A  careful  pre-
operative  evaluation  of  the  patient  is  essential  if 
blood loss is to be reduced and appropriate plans 
for transfusion alternatives are to be made. The pre-
operative measurement of the hemoglobin level and 
hematocrit  will  detect  the  presence  of  anemia. 
Ensuring  adequate  hemoglobin  levels  pre-
operatively  will  reduce  the  likelihood  of  blood 
transfusion during surgery. In a study by Carmel et 
al
1,  exertional  dyspnea  did  not  occur  until  the 
hemoglobin concentration fell to <7g/dl. In another 
study,  at  levels  <6g/dl,  only  54%  of  patients 
experienced  tachycardia,  32%  had  hypotension, 
35%  had  impaired  consciousness,  and  27%  had 
dyspnea.
2 In a study on patients with hip fracture 
aged more than 60 years, 55.6% patients received 
transfusion at a hemoglobin 8g/dl or higher while 
90.5% received transfusion at a hemoglobin level 
less  than  8g/dl.  Only  6.6%  of  patients  with 
postoperative  hemoglobin  of  10g/dl  received  a 
transfusion. The post operative mortality was not 
affected.
3  Recent Cochrane review on transfusion Kaur et al / Transfusion issues in surgery 
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triggers states that restrictive transfusion strategies 
reduce  the  risk  of  receiving  a  red  blood  cell 
transfusion  by  37%  and  lead  to  an  absolute  risk 
reduction of 33%. The restrictive strategies did not 
impact  the  rate  of  adverse  events  compared  to 
liberal  transfusion  strategies  but  were  associated 
with significant reduction in the rates of infection.
4 
Preoperative  cross  matching  of  blood  units  for 
surgical  patients  is  performed  in  anticipation  of 
potential  need  which  may  not  materialize  and 
consequently many blood units are cross matched 
before  surgery  that  are  never  transfused.  Cross 
matching  blood  that  is  not  transfused  consumes 
blood  bank  resources  unnecessarily  and  requires 
more  maintenance  of  the  blood  inventory.  This 
leads  to  increase  in  the  number  of  units  that 
become  outdated.  These  patients  can  be  better 
served  by  performing  only  a  type  and  antibody 
screen. If in a rare instance blood is required for 
transfusion, group specific blood can be released in 
the  absence  of  a  positive  antibody  screen. 
Immediate spin cross match can be performed prior 
to release of blood.  In order to limit the number of 
units held out of the circulation and outdating of 
blood units, a Maximum Surgical Blood Ordering 
Schedule (MSBOS) recommends that for patients 
likely to be transfused during surgery, the number 
of cross matched units should be twice the medium 
requirement  for  that  surgical  procedure  (Cross 
match to Transfusion ratio or C.T. ratio 2:1).
5,6 
 
PRE  OPERATIVE  CORRECTION  OF 
ANEMIA 
 
The  National  Institutes  of  Health  Preoperative 
Consensus  Conference  concluded  that  “otherwise 
healthy patients with hemoglobin values of 10g/dl 
or  greater  rarely  require  preoperative  transfusion, 
whereas,  those  with  acute  anemia  with  resulting 
hemoglobin  values  of  less  than  7g/dl  will 
frequently require red cell transfusions”. Whether 
patients  with  hemoglobin  values  between  7  and 
10g/dl should receive transfusions depends on the 
patient’s clinical status.
7 The American Society of 
Anesthesiologists task force on perioperative blood 
transfusion suggest that red blood cells are usually 
administered when hemoglobin is less than 6gm/dl 
in  young  healthy  patient  and  are  usually  not 
required when hemoglobin is more than 10gm/dl. 
Hemoglobin  levels  between  6gm/dl  and  10gm/dl, 
need  based  transfusions  may  be  given  based  on 
ongoing  indication  of  organ  ischemia,  potential 
bleeding, patient’s intravascular volume status and 
risk for complications of inadequate oxygenation.
8 
The  minimum  acceptable  level  of  hemoglobin 
varies for patients because individual persons may 
vary in their ability to tolerate and compensate for 
anemia.  If  a  preoperative  patient  is  anemic,  an 
attempt  should  be  made  to  find  and  treat  the 
underlying  cause.  Anemia  resulting  from 
nutritional deficiencies is correctable but treatment 
takes weeks to months. If surgical procedures are 
required sooner, red blood cell transfusions may be 
given  preoperatively  to  correct  the  anemia.  In  a 
recent study, the perioperative use of intravenous 
iron as a transfusion alternative was evaluated. The 
use of intravenous iron therapy was found to reduce 
the proportion of patients requiring transfusion and 
the  number  of  units  transfused.  The 
multidisciplinary  panel  recommended  intravenous 
iron administration to patients undergoing surgery 
and  expected  to  develop  post  operative  anemia.
9 
Kitchens studied the rate of fatal complications due 
to anemia in 16 reports of the surgical outcome in 
Jehovah’s  Witness  patients.  All  together,  there 
were  1,404  procedures  represented  resulting  in  a 
mortality  rate  due  to  anemia  of  between  0.5  to 
1.5%.
10  More  often,  a  hospital-wide  transfusion 
trigger  policy  is  in  place  that  may  support 
transfusions  at  very  conservative  hemoglobin 
concentrations.  It  is  therefore  more  difficult  to 
determine the risk of transfusing too conservatively 
versus  more  liberally.  Patients  who  donate  blood 
for  autologous  transfusion  may  have  a  lower 
preoperative  hemoglobin  concentration  and  are 
more likely to receive a red cell transfusion in the 
event  of  operative  blood  loss.  This  can  be 
prevented by not taking autologous donations from 
patients  who  are  unlikely  to  need  a  transfusion 
during surgery. If at all such patients make them, 
donations should be made early to allow sufficient 
time for red cell regeneration. 
 
INTRAOPERATIVE  BLOOD  LOSS  AND 
TRANSFUSION 
 
Red  blood  cells  may  be  urgently  needed  for  the 
surgical  patient  because  of  unexpected  rapid  and 
large  amount  of  blood  loss.  If  such  a  situation 
arises, blood may be issued by the emergency spin 
cross  match  technique  with  the  consent  of  the 
treating  physician.  This  abbreviated  technique 
detects  any  major  ABO  incompatibility  between 
the  patient  and  the  donor.
11  Routine  cross  match 
procedure is to be followed even after the unit is 
issued  by  emergency  spin  cross  match  technique 
and the unit may be retrieved back by the blood 
center  if  any  incompatibility  is  detected.    The 
surgeons and anesthesiologists should consult the 
transfusion medicine specialists and weigh the risks 
of an emergency transfusion versus a routine blood 
transfusion with complete compatibility testing.  
Reduction of intraoperative blood loss 
In  addition  to  meticulous  surgical  hemostasis, 
intraoperative blood loss can be reduced by use of 
vasoconstrictors  and  intraoperative  and 
postoperative salvage of blood in major surgeries.
12 
Blood  loss  reduction  drugs  like  desmopressin, 
antifibrinolytic  agents  (Tranexamic  acid,  Epsilon 
amino caproic acid and aprotinin) and local fibrin Kaur et al / Transfusion issues in surgery 
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glue  or  sealant  have  been  used  to  decrease  local 
bleeding in surgical procedures. 
The key objective is to ensure normovolemia at all 
times  during  a  surgical  procedure.  Hence,  the 
rational approach should be replacement of surgical 
blood  loss  with  crystalloid  or  colloid  fluids  to 
maintain  normovolemia.  ANH  is  a  form  of 
autologous blood donation that occurs immediately 
preoperatively  after  anesthesia  is  induced  and 
before surgery begins.
13-15 The concept is that the 
hemoglobin  concentration  in  the  patient  is 
aggressively  reduced  under  careful  monitoring  of 
cardiovascular  function  and  tissue  oxygenation. 
The units of collected blood are set-aside at room 
temperature  to  be  reinfused  at  the  end  of  the 
procedure.  The  volume  is  replaced  with  acellular 
fluid;  either  colloid  (at  a  1:1  ratio  with  volume 
removed) or crystalloid (at a 1:3 ratio).
16 Since the 
volume of blood loss at surgery is not affected by 
having  diluted  the  patient’s  hemoglobin 
concentration,  the  blood  that  is  shed  results  in 
reduced absolute RBC loss.  This can take care of a 
significant  degree  of  blood  loss  before  a  blood 
transfusion  becomes  necessary.  The  goal  of  red 
blood  cell  transfusion  is  to  prevent  inadequate 
oxygenation,  which  causes  tissue  ischemia  and 
damage.  Hypovolemia  and  hypoxemia  can  also 
cause  tissue  ischemia  and  damage.  Prolonged 
inadequate oxygenation that causes enough tissue 
damage  can  result  in  disseminated  intravascular 
coagulation  and  a  bleeding  diathesis 
intraoperatively.  It  would  be  prudent  to  monitor 
and distinguish between inadequate blood volume, 
inadequate arterial oxygen content and inadequate 
oxygen carrying capacity. These factors can occur 
together  or  separately.  Therapy  must  be  directed 
appropriately to increase blood volume with fluids, 
arterial  oxygen  content  by  inspired  oxygen,  or 
hemoglobin  concentration  by  red  blood  cell 
transfusion.  A  recent  prospective  randomized 
randomized  control  trial  concluded  that  intra 
operative fluid restriction reduces peri operative red 
blood cell transfusion in elective cardiac surgery, 
especially in transfusion prone patients.
17 Another 
multicenter observational study suggests that intra 
operative blood transfusion in non cardiac surgical 
setting is associated with a higher risk of mortality 
and  morbidity  in  patients  with  severe  anemia 
(hematocrit less than 30%).
18 
The  decision  to  transfuse  blood  to  the  patient 
should  be  based  on  estimation  of  volume  of 
surgical  blood  loss,  rate  of  blood  loss,  patient’s 
clinical response to blood loss and signs indicating 
inadequate  tissue  oxygenation.  A  judgment  is 
required to decide on the percent blood volume that 
can  be  safely  lost  or  the  lowest  hemoglobin  (or 
hematocrit) that can be tolerated. The ability of a 
patient to compensate for blood loss will be limited 
by  age,  preexisting  anemia,  and  evidence  of 
cardiorespiratory illness and use of drugs such as 
beta blockers.
19 
 
POSTOPERATIVE TRANSFUSION ISSUES 
 
Blood  loss  and  hypovolemia  can  develop  in  the 
postoperative period. Its prevention, early detection 
and  treatment  are  of  utmost  importance  for  the 
patient’s welfare and may again reduce the need for 
unnecessary  transfusion.  Special  attention  should 
be  paid  to  postoperative  hypoxia,  monitoring  of 
vital  signs,  fluid  balance  and  analgesia.  Authors 
have observed that higher intraoperative plasma to 
red blood cell transfusion ratio is associated with 
fewer plasma and red cell requirement in first 24 
hours  after  surgery.  They  have  also  observed 
benefit  of  aggressive  intraoperative  plasma  to 
correct perioperative coagulopathy.
20 
Staff caring for patients post operatively should be 
aware  that  some  degree  of  hemodilution  can  be 
expected  in  patients  who  have  undergone 
intraoperative blood loss. As a result, postoperative 
hemoglobin  level  is  likely  to  be  lower  than  the 
preoperative level. This alone is not an indication 
for  blood  transfusion.  Postoperative  hemoglobin 
drift  can  occur  over  a  seven-day  period  due  to 
various factors such as hemodilution, post surgical 
blood  loss  and  phlebotomy  for  diagnostic  tests.
20 
The decision to transfuse should be made after a 
careful assessment of the general condition of the 
patient,  coexisting  cardiopulmonary  illness,  signs 
of  inadequate  tissue  oxygenation  and  continued 
blood loss. In the later post operative period, iron 
supplementation  will  optimize  the  erythropoietic 
response  and  restore  the  hemoglobin  values  to 
normal  more  rapidly.  Authors  have  observed  a 
postoperative transfusion trigger of 8gm/dl as safe 
in  hemodynamically  stable  patients.
21  A 
multivariate analysis showed a significant relation 
between  post  operative  transfusion  and  estimated 
blood loss but no relation was observed between 
age, gender, body mass index, duration of surgery, 
type  of  anesthesia  and  pre  operative  hemoglobin 
levels.
22 Several studies have established a relation 
between pre operative hemoglobin level and post 
operative requirement of blood transfusion.
23,24 
 
SPECIAL CIRCUMSTANCES 
 
Emergency Transfusion: In extreme emergencies 
when there is no time to obtain and test a sample, 
group  ‘O’  Rh  negative  packed  red  cells  can  be 
released. In such a situation the clinician must give 
a  written  consent  authorizing  and  accepting 
responsibility  for  the  use  of  incompletely  tested 
products as a life saving measure. An emergency 
issue procedure can be used to issue several units 
of red blood cells and have them delivered to the 
operating room within minutes. With this system, 
82% of the units reached the operating room within Kaur et al / Transfusion issues in surgery 
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2  minutes  of  request,  91%  within  3  minutes  and 
100% within 4 minutes thus preventing any delay 
in transfusion.
25 
 
Massive Transfusion: It is defined as transfusion 
approximating  or  exceeding  the  patients  blood 
volume  or  transfusion  of  more  than  10  units  of 
blood within 24 hours.
26 Replacement of more than 
50% of circulating blood volume in less than three 
hours  or  transfusion  at  the  rate  of  more  than 
150ml/minute  is  also  considered  as  massive 
transfusion.
27  Massive  (or  large  volume) 
transfusions  generally  arise  as  a  result  of  acute 
hemorrhage  in  surgical  patients.  A  blood  loss  of 
less  then  20%  of  the  total  blood  volume  is 
generally well tolerated, loss of 20% to 40% will 
cause  change  in  the  vital  signs  with  evidence  of 
impaired tissue perfusion. However, loss of greater 
than  40%  of  blood  volume  may  lead  to  frank 
hemorrhagic  shock  and  progress  to  circulatory 
system failure and cardiac arrest if not corrected.
28 
Ideally a massive transfusion protocol should be in 
place  to  obtain  the  needed  products  in  a  timely 
manner.  One  protocol  suggests  transfusion  of  2 
units of fresh frozen plasma (FFP) for every 4 units 
of packed red blood cells (PRBC), a pooled unit of 
random platelets after every 8th PRBC and a 10-
pack  cryoprecipitate  by  the  16th  PRBC.  Besides, 
calcium should be administered and therapy should 
be guided by laboratory results. The main aim of a 
massive  transfusion  protocol  is  to  counteract  the 
coagulopathy  associated  with  massive  transfusion 
of red cells leading to dilution of clotting factors 
and  sequestration  and  activation  of  platelets  at 
bleeding sites.
29 
Whereas  all  transfusions  have  potential  adverse 
reactions,  the  transfusion  of  massive  amounts  of 
stored  blood  is  associated  with  unique 
consequences, such as shift to the left in the oxygen 
dissociation  curve,  acid  base  imbalance, 
hypothermia,  hypocalcaemia,  dilutional 
coagulopathy  and  respiratory  distress.  The 
American College of Surgeons and the American 
Association of Blood Banks both recommend that 
the  transfusion  of  blood  and  blood  components 
should be guided by laboratory tests such as PT, 
PTT, platelet count and fibrinogen levels. Minimal 
level of coagulation factors are required for normal 
formation  of  fibrin  and  hemostasis,  so  normal 
plasma  contains  coagulation  factors  in  excess,  a 
reserve  that  usually  allows  patients  to  tolerate 
replacement of one or more blood volumes of red 
cells and crystalloid without needing fresh frozen 
plasma. Guidelines typically state that the threshold 
for therapeutic or prophylactic fresh frozen plasma 
is PT 1.5 times upper limit of normal or the mid 
point  of  the  normal  range  and  a  PTT  1.5  times 
upper  limit  of  normal  in  an  appropriate  clinical 
setting.
30,31  Use  of  FFP  in  cases  of  surgical  or 
traumatic  bleeding  should  be  guided  by  clotting 
studies.
32  In  the  event  of  microvascular  bleeding, 
empiric therapy with platelets and/or plasma may 
be  initiated  immediately  after  specimens  are 
obtained. Besides periodic visual assessment of the 
surgical  field,  an  assessment  of  microvascular 
bleeding should be done with the surgical team. In 
the  event  of  micro  vascular  bleeding  empiric 
therapy  with  platelets  and/or  plasma  may  be 
initiated immediately after specimens are obtained. 
In  consumptive  coagulopathy  a  platelet  count  of 
less  than  50000/µl  and  fibrinogen  level  less  than 
100mg/dl are better predictors of hemorrhage than 
PT and aPPT.
33 The supplementation of FFP should 
be  considered  after  one  volume  is  lost  and 
definitely started before blood loss equals to 150%. 
At this stage 4-5 units of FFP should be infused and 
subsequently 4 units FFP for every 6 units of red 
cells.
31  Some  authors  suggest  that  massive 
transfusion protocols should utilize a 1:1 ratio of 
plasma  to  RBCs  for  all  patients  who  are 
hypocoagulable  with  traumatic  injuries.
34  Others 
suggest that hemostasis is usually maintained when 
coagulation  protein  is  25%  of  normal.  Hence,  2 
units  of  FFP  should  be  transfused  initially  to  a 
patient  with  deranged  international  normalized 
ratio results and/or wide spread capillary bleeding, 
since  routine  practice  of  transfusing  FFP  after  a 
certain  number  of  PRBC  units  may  lead  to 
excessive  transfusion  and  wastage  of  FFP.
35 
Investigators have even proposed introduction of a 
transfusion package in the form of 5 PRBC units, 5 
thawed  plasma  units  and  two  pooled  platelet 
concentrates  to  be  administered  in  parallel.  This 
provided  a  hematocrit  of  30%,  a  clotting  factor 
concentration  above  40%  and  platelet  count  of 
about 80×109/l.
36 Platelets are usually administered 
when  platelet  count  falls  below  50,000/µl  and  is 
associated with bleeding. Platelet transfusion may 
be considered if platelet count is between 50,000 
and  1,00,000/µl  based  on  anticipated  or  ongoing 
bleeding.
8 Whatever the protocol be, judicious use 
of  the  appropriate  component  in  the  appropriate 
quantity at the right time can save a precious and 
scarce  resource  and  at  the  same  time  benefit  the 
right patient. 
 
CONCLUSION 
 
Blood transfusion practices in elective surgery have 
been  shown  remarkably  inconsistent.  There  are 
wide  variations  in  blood  usage  for  the  same 
procedure.  Preoperative  assessment  of  the  patient 
for the presence of anemia and its correction can 
prevent the need for allogeneic transfusion during 
surgery. Reduction of intraoperative blood loss by 
several methods such as surgical hemostasis, blood 
salvage  and  use  of  drugs  can  also  limit  the 
transfusion  requirement  to  some  extent.  Post 
operatively  the  patients  should  be  monitored  for 
identifying early signs of hypovolemia and blood Kaur et al / Transfusion issues in surgery 
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loss.  There  is  no  substitute  for  clinical  judgment 
based on observation of the patient and appropriate 
hemodynamic  monitoring.  The  added  risks  of 
transfusion  reactions,  infections  and  metabolic 
complications associated with massive transfusion 
should  curtail  the  indiscriminate  or  routine 
prophylactic use of allogeneic blood products. 
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